NeoGenomics (NEO)
(Delayed Data from NSDQ)
$16.28 USD
-0.20 (-1.21%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $16.30 +0.02 (0.12%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum B VGM
NeoGenomics (NEO) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$21.09 | $30.00 | $18.00 | 27.97% |
Price Target
Based on short-term price targets offered by 11 analysts, the average price target for NeoGenomics comes to $21.09. The forecasts range from a low of $18.00 to a high of $30.00. The average price target represents an increase of 27.97% from the last closing price of $16.48.
Analyst Price Targets (11)
Broker Rating
NeoGenomics currently has an average brokerage recommendation (ABR) of 1.54 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 13 brokerage firms. The current ABR compares to an ABR of 1.54 a month ago based on 13 recommendations.
Of the 13 recommendations deriving the current ABR, nine are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 69.23% and 7.69% of all recommendations. A month ago, Strong Buy made up 69.23%, while Buy represented 7.69%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 9 | 9 | 9 | 9 | 9 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.54 | 1.54 | 1.54 | 1.54 | 1.54 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/31/2024 | Cowen & Co. | Daniel Brennan | Strong Buy | Strong Buy |
7/30/2024 | Needham & Company | Michael Matson | Moderate Buy | Moderate Buy |
7/30/2024 | William Blair | Andrew F Brackmann | Strong Buy | Strong Buy |
7/30/2024 | Piper Sandler | David M Westenberg | Strong Buy | Strong Buy |
7/30/2024 | Stephens | Mason Carrico | Strong Buy | Strong Buy |
7/29/2024 | SVB Securities | Puneet Souda | Strong Buy | Strong Buy |
5/1/2024 | Craig-Hallum | Matthew G Hewitt | Not Available | Strong Buy |
5/1/2024 | The Benchmark Company | Bruce D Jackson | Strong Buy | Strong Buy |
2/27/2024 | BTIG | Mark Massaro | Strong Buy | Strong Buy |
2/22/2024 | Goldman Sachs | Matthew Sykes | Strong Buy | Strong Buy |
2/21/2024 | Raymond James | Andrew Cooper | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.54 |
ABR (Last week) | 1.54 |
# of Recs in ABR | 13 |
Average Target Price | $21.09 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 79 of 253 |
Current Quarter EPS Est: | 0.01 |
NEO FAQs
NeoGenomics, Inc. (NEO) currently has an average brokerage recommendation (ABR) of 1.54 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 13 brokerage firms.
The average price target for NeoGenomics, Inc. (NEO) is $21.09. The current on short-term price targets is based on 7 reports.
The forecasts for NeoGenomics, Inc. (NEO) range from a low of $18 to a high of $30. The average price target represents a increase of $29.55 from the last closing price of $16.28.
The current UPSIDE for NeoGenomics, Inc. (NEO) is 29.55%
Based on short-term price targets offered by 11 analysts, the average price target for NeoGenomics comes to $21.09. The forecasts range from a low of $18.00 to a high of $30.00. The average price target represents an increase of 27.97% from the last closing price of $16.48.